OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance
Daisy Yan, One Hyuk, Bingfang Yan
Animal Diseases (2021) Vol. 1, Iss. 1
Open Access | Times Cited: 6
Daisy Yan, One Hyuk, Bingfang Yan
Animal Diseases (2021) Vol. 1, Iss. 1
Open Access | Times Cited: 6
Showing 6 citing articles:
Viral target and metabolism‐based rationale for combined use of recently authorized small molecule COVID‐19 medicines: Molnupiravir, nirmatrelvir, and remdesivir
Daisy Yan, Bingfang Yan
Fundamental and Clinical Pharmacology (2023) Vol. 37, Iss. 4, pp. 726-738
Open Access | Times Cited: 10
Daisy Yan, Bingfang Yan
Fundamental and Clinical Pharmacology (2023) Vol. 37, Iss. 4, pp. 726-738
Open Access | Times Cited: 10
Comparable Efficacy of Lopinavir/Ritonavir and Remdesivir in Reducing Viral Load and Shedding Duration in Patients with COVID-19
Choon-Mee Kim, Jae Keun Chung, Sadia Tamanna, et al.
Microorganisms (2024) Vol. 12, Iss. 8, pp. 1696-1696
Open Access | Times Cited: 3
Choon-Mee Kim, Jae Keun Chung, Sadia Tamanna, et al.
Microorganisms (2024) Vol. 12, Iss. 8, pp. 1696-1696
Open Access | Times Cited: 3
The COVID-19 Oral Drug Molnupiravir Is a CES2 Substrate: Potential Drug-Drug Interactions and Impact of CES2 Genetic Polymorphism In Vitro
Yue Shen, William Eades, William Liu, et al.
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 9, pp. 1151-1160
Open Access | Times Cited: 17
Yue Shen, William Eades, William Liu, et al.
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 9, pp. 1151-1160
Open Access | Times Cited: 17
Failed clinical trials on COVID-19 acute respiratory distress syndrome in hospitalized patients: common oversights and streamlining the development of clinically effective therapeutics
Denise Battaglini, Fernanda F. Cruz, Chiara Robba, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 995-1015
Closed Access | Times Cited: 6
Denise Battaglini, Fernanda F. Cruz, Chiara Robba, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 995-1015
Closed Access | Times Cited: 6
Effect of alcohol exposure on the efficacy and safety of tenofovir alafenamide fumarate, a major medicine against human immunodeficiency virus
William Liu, Sarah Yu, Bingfang Yan
Biochemical Pharmacology (2022) Vol. 204, pp. 115224-115224
Open Access | Times Cited: 3
William Liu, Sarah Yu, Bingfang Yan
Biochemical Pharmacology (2022) Vol. 204, pp. 115224-115224
Open Access | Times Cited: 3
Metabolism Pathways of Major Therapeutics for Treating Monkeypox Mono- and Co-infection with Human Immunodeficient Virus or SARS-CoV-2
Daisy Yan, Bingfang Yan
Current Drug Metabolism (2023) Vol. 24, Iss. 4, pp. 240-249
Open Access
Daisy Yan, Bingfang Yan
Current Drug Metabolism (2023) Vol. 24, Iss. 4, pp. 240-249
Open Access
